FIELD: medicine.
SUBSTANCE: method for proliferation of Lak cells provides recovery of an initial sample containing αβ-type T-cell from a dog or a cat. It is followed by cell proliferation/activation by cell culture in a culture medium containing concanavalin A and interleukin-2. What is also disclosed is a kit for implementing such method.
EFFECT: method provides producing the Lak cells effective against various types of cancer, against immunodeficiency-caused diseases and infections.
8 cl, 14 dwg, 7 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| REPRODUCTION AND USE OF NON-HEMATOPOIETIC TISSUE-RESIDENT γδ T-CELLS | 2016 |
|
RU2784566C2 |
| METHOD OF HUMAN REGULATORY CD4CD25FOXP3T-CELL ENRICHMENT ex vivo | 2010 |
|
RU2437933C1 |
| METHOD OF OBTAINING POPULATION OF HUMAN CD4+CD25+Foxp3+ T-LYMPHOCYTES ex vivo, DISEASE TREATMENT METHOD | 2008 |
|
RU2391401C2 |
| METHOD OF PRODUCING CELL LINES STABLY PRODUCING HUMAN MONOCLONAL ANTIBODIES OF CLASS IGG | 2018 |
|
RU2741095C2 |
| METHOD FOR LONG-TERM CULTIVATION AND EXPANSION OF NK CELLS WITH HIGH VIABILITY AND FUNCTIONAL ACTIVITY | 2021 |
|
RU2794770C1 |
| METHOD FOR PRECLINICAL TESTING OF IMMUNOMODULATORY AGENTS | 2010 |
|
RU2519641C2 |
| AUTOLOGOUS VACCINE FOR ONCOTHERAPY AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2392946C2 |
| PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE TREATMENT | 2000 |
|
RU2203682C2 |
| METHOD OF INTERLEUKIN-1 DETERMINATION IN HUMAN MONOCYTES | 0 |
|
SU1730594A1 |
| METHOD OF CYTOGENETIC ACTIVATION OF HUMAN LYMPHOCYTES | 2015 |
|
RU2603079C2 |
